Regeneron · 1 day ago
Associate Scientist, Keloid & Fibrosis
Regeneron is a leading biotechnology company, and they are seeking a highly motivated Associate Scientist to join their Keloid and Fibrosis Team. The successful candidate will contribute to target discovery and validation work, building a platform of in vitro and in vivo models to evaluate keloid and fibrosis targets.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Conducting in vitro experiments and running a variety of molecular biology, immunological, and cell-based assays (western blot, qRT-PCR, immunohistochemistry, ELISAs, etc.)
Managing in vivo mouse models, performing injections (intraperitoneal, subcutaneous, intravenous), surgeries, and tissue dissections
Managing intake for human tissue samples and isolating primary cells from these samples for in vitro assays and single-cell analysis
Qualification
Required
Bachelor's or Master's degree in biology or a related field
At least 0-3 years of relevant research experience
Excellent analytical skills
Exceptional communication skills
Ability to work effectively with others
Demonstrated experience with molecular biology techniques
Preferred
Prior experience in skin research and/or fibrosis/fibroblast biology
Previous work with mouse models
Expertise in primary cell culture/in vitro models
Understanding of single-cell transcriptomics
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
2026-01-13
2026-01-09
Company data provided by crunchbase